Viewing StudyNCT02690701



Ignite Creation Date: 2024-05-06 @ 8:12 AM
Last Modification Date: 2024-10-26 @ 11:57 AM
Study NCT ID: NCT02690701
Status: COMPLETED
Last Update Posted: 2021-01-05
First Post: 2016-02-19

Brief Title: Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Chronic Plaque Psoriasis
Keywords:
Name View
psoriasis View
plaque psoriasis View
secukinumab View
AIN457 View
biologic View
monoclonal antibody View
aortic vascular inflammation View